An alpha-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes. 1999

S J Kim, and K Iizuka, and R A Kelly, and Y J Geng, and S P Bishop, and G Yang, and A Kudej, and B K McConnell, and C E Seidman, and J G Seidman, and S F Vatner
Cardiovascular and Pulmonary Research Institute, Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania 15212, USA.

Left Ventricular (LV) myocytes were isolated from 15-wk-old male mice bearing the Arg403 --> Gln alpha-cardiac myosin heavy chain missense mutation (alpha-MHC403/+), a model of familial hypertrophic cardiomyopathy. LV myocytes were classified morphologically: type I, rod shaped with parallel myofibrils; type II, irregularly shaped, shorter and wider than wild-type (WT) control cells, with parallel myofibrils; and type III, irregularly shaped with disoriented myofibrils. Compared with WT myocytes, alpha-MHC403/+ myocytes had fewer type I cells (WT = 74 +/- 3%, alpha-MHC403/+ = 41 +/- 4%, P < 0.01) and more type III cells (WT= 12 +/- 3%, alpha-MHC403/+ = 49 +/- 7%, P < 0.01). In situ histology also demonstrated marked myofibrillar disarray in the alpha-MHC403/+ hearts. With the use of video edge detection, myocytes were paced at 1 Hz (37 degrees C) to determine the effects of the mutation on myocyte function. End-diastolic length was reduced in mutant myocytes, but fractional shortening (% contraction) and sarcomere length were not. Velocity of contraction (-dL/dtmax) was depressed in mutant cells, but more in type II and III cells (-31%) than in type I cells (-18%). Velocity of relaxation (+dL/dt) was also depressed more in type II and III cells (-38%) than in type I cells (-16%). Using fura 2 dye with intracellular Ca2+ transients, we demonstrated that in alpha-MHC403/+ myocytes, the amplitude of the Ca2+ signal during contraction was unchanged but that the time required for decay of the signal to decrease 70% from its maximum was delayed significantly (WT = 159 +/- 8 ms; alpha-MHC403/+ = 217 +/- 14 ms, P < 0.01). Sarco(endo)plasmic reticulum Ca2+-ATPase mRNA levels in alpha-MHC403/+ and WT mice were similar. These data indicate that the altered cardiac dysfunction of alpha-MHC403/+ myocytes is directly due to defective myocyte function rather than to secondary changes in global cardiac function and/or loading conditions.

UI MeSH Term Description Entries
D008297 Male Males
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006352 Heart Ventricles The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation. Cardiac Ventricle,Cardiac Ventricles,Heart Ventricle,Left Ventricle,Right Ventricle,Left Ventricles,Right Ventricles,Ventricle, Cardiac,Ventricle, Heart,Ventricle, Left,Ventricle, Right,Ventricles, Cardiac,Ventricles, Heart,Ventricles, Left,Ventricles, Right
D000200 Action Potentials Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli. Spike Potentials,Nerve Impulses,Action Potential,Impulse, Nerve,Impulses, Nerve,Nerve Impulse,Potential, Action,Potential, Spike,Potentials, Action,Potentials, Spike,Spike Potential
D000252 Calcium-Transporting ATPases Cation-transporting proteins that utilize the energy of ATP hydrolysis for the transport of CALCIUM. They differ from CALCIUM CHANNELS which allow calcium to pass through a membrane without the use of energy. ATPase, Calcium,Adenosinetriphosphatase, Calcium,Ca(2+)-Transporting ATPase,Calcium ATPase,Calcium Adenosinetriphosphatase,Adenosine Triphosphatase, Calcium,Ca2+ ATPase,Calcium-ATPase,ATPase, Ca2+,ATPases, Calcium-Transporting,Calcium Adenosine Triphosphatase,Calcium Transporting ATPases,Triphosphatase, Calcium Adenosine

Related Publications

S J Kim, and K Iizuka, and R A Kelly, and Y J Geng, and S P Bishop, and G Yang, and A Kudej, and B K McConnell, and C E Seidman, and J G Seidman, and S F Vatner
March 1992, Biochemical and biophysical research communications,
S J Kim, and K Iizuka, and R A Kelly, and Y J Geng, and S P Bishop, and G Yang, and A Kudej, and B K McConnell, and C E Seidman, and J G Seidman, and S F Vatner
July 2004, Endocrine,
S J Kim, and K Iizuka, and R A Kelly, and Y J Geng, and S P Bishop, and G Yang, and A Kudej, and B K McConnell, and C E Seidman, and J G Seidman, and S F Vatner
August 2006, Revista espanola de cardiologia,
S J Kim, and K Iizuka, and R A Kelly, and Y J Geng, and S P Bishop, and G Yang, and A Kudej, and B K McConnell, and C E Seidman, and J G Seidman, and S F Vatner
July 2001, Cell and tissue research,
S J Kim, and K Iizuka, and R A Kelly, and Y J Geng, and S P Bishop, and G Yang, and A Kudej, and B K McConnell, and C E Seidman, and J G Seidman, and S F Vatner
April 2007, Circulation research,
S J Kim, and K Iizuka, and R A Kelly, and Y J Geng, and S P Bishop, and G Yang, and A Kudej, and B K McConnell, and C E Seidman, and J G Seidman, and S F Vatner
December 1993, Genomics,
S J Kim, and K Iizuka, and R A Kelly, and Y J Geng, and S P Bishop, and G Yang, and A Kudej, and B K McConnell, and C E Seidman, and J G Seidman, and S F Vatner
February 1994, The Journal of biological chemistry,
S J Kim, and K Iizuka, and R A Kelly, and Y J Geng, and S P Bishop, and G Yang, and A Kudej, and B K McConnell, and C E Seidman, and J G Seidman, and S F Vatner
January 1999, The Journal of clinical investigation,
S J Kim, and K Iizuka, and R A Kelly, and Y J Geng, and S P Bishop, and G Yang, and A Kudej, and B K McConnell, and C E Seidman, and J G Seidman, and S F Vatner
September 1995, American journal of medical genetics,
S J Kim, and K Iizuka, and R A Kelly, and Y J Geng, and S P Bishop, and G Yang, and A Kudej, and B K McConnell, and C E Seidman, and J G Seidman, and S F Vatner
September 1998, Journal of molecular and cellular cardiology,
Copied contents to your clipboard!